Acute Myeloid Leukemia Practice Pearls: Key Points in Pathway Identification
AML Content Hub
In this “Practice Pearls” roundtable organized by Pharmacy Times, expert panelists discuss acute myeloid leukemia (AML) diagnosis and the various factors affecting decision-making for specialists treating patients with AML. Learn more by clicking here. Panelists:
- Katie Culos, PharmD, BCOP
Hematology/Oncology Clinical Pharmacist – Vanderbilt University Medical Center
Nashville, Tennessee - Amanda Brahim, PharmD, BCOP, BCPS, BCACP
Hematology/Oncology Clinical Pharmacist – Memorial Cancer Institute
Pembroke Pines, Florida - Yehuda Deutsch, MD
Hematologist/Oncologist – Department of Malignant Hematology and Cellular Therapy – Memorial Cancer Institute
Pembroke Pines, Florida
